ENTITY

Tellgen Corp (300642 CH)

3
Analysis
Health CareChina
Tellgen Corporation researches, manufactures, and distributes in vitro diagnostic reagents. The Company produces tumor marker testing series, human papillomavirus detection products, gene mutation detection products, and more. Tellgen serves customers worldwide.
more
Refresh
07 Aug 2022 09:22

China Healthcare Weekly (Aug.5) - HK IPO, Innovent, BeiGene, the Largest IVD Centralized Procurement

IVD field ushered in the largest VBP in history. Innovent/Sanofi reached major cooperation, and Innovent’s CCO resigned. We deep dived the logic...

Logo
259 Views
Share
28 Apr 2022 08:52

Autobio Diagnostics Co Ltd (603658.CH) - Logic Changes

It's not wise for Autobio to quit chemiluminescence centralized procurement in Anhui.The failure of seizing COVID-19 testing opportunity and weak...

Logo
241 Views
Share
04 Jul 2021 09:06

China Healthcare Weekly (July.2)

The article analyzed the new document about the development of TCM and western medicine,potential start time of VBP on biosimilar...

Logo
208 Views
Share
No more insights
x